Testosterone Enanthate is used for: Inoperable metastatic breast cancer; Delayed puberty; Male hypogonadism.
Recorded in the NepalDoc medicine catalog for Testosterone Enanthate.
Males Testosterone enanthate injection is indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired) – Testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy.
From the U.S. FDA-approved label for Testosterone Enanthate. Full label: DailyMed.
Males Testosterone enanthate injection is indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired) – Testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy. Hypogonadotropic hypogonadism (congenital or acquired) – Gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. (Appropriate adrenal cortical and thyroid hormone replacement therapy are still necessary, however, and are actually of primary importance.) If the above conditions occur prior to puberty, androgen replacement therapy will be needed during the adolescent years for development of secondary sexual characteristics. Prolonged androgen treatment will be required to maintain sexual characteristics in these and other males who develop testosterone deficiency after puberty. Safety and efficacy of testosterone enanthate injection in men with age-related hypogonadism have not been established.
From the U.S. FDA-approved label for Testosterone Enanthate. Full label: DailyMed.
Prior to initiating testosterone enanthate injection, confirm the diagnosis of hypogonadism by ensuring that serum testosterone concentrations have been measured in the morning in the morning on at least two separate days and that these serum testosterone concentrations are below the normal range. Dosage and duration of therapy with testosterone enanthate injection will depend on age, sex, diagnosis, patient’s response to treatment, and appearance of adverse effects. When properly given, injections of testosterone enanthate are well tolerated.
Directions from the U.S. FDA-approved label for Testosterone Enanthate — your doctor or pharmacist may advise differently.
Androgens are contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant. When administered to pregnant women, androgens cause virilization of the external genitalia of the female fetus. This virilization includes clitoromegaly, abnormal vaginal development, and fusion of genital folds to form a scrotal-like structure.
Excerpt from the U.S. FDA-approved label for Testosterone Enanthate. Talk to a pharmacist or doctor before use.
In patients with breast cancer and in immobilized patients, androgen therapy may cause hypercalcemia by stimulating osteolysis. In patients with cancer, hypercalcemia may indicate progression of bony metastasis. If hypercalcemia occurs, the drug should be discontinued and appropriate measures instituted. Prolonged use of high doses of androgens has been associated with the development of peliosis hepatis and hepatic neoplasms including hepatocellular carcinoma (see PRECAUTIONS, Carcinogenesis ). Peliosis hepatis can be a life-threatening or fatal complication.
Warnings and precautions excerpt from the U.S. FDA-approved label for Testosterone Enanthate — not a complete list. Talk to a pharmacist or doctor before use.
Endocrine and Urogenital, Female – The most common side effects of androgen therapy are amenorrhea and other menstrual irregularities, inhibition of gonadotropin secretion, and virilization, including deepening of the voice and clitoral enlargement. The latter usually is not reversible after androgens are discontinued.
Excerpt from the U.S. FDA-approved label for Testosterone Enanthate — not a complete list. Talk to a pharmacist or doctor about side effects.
6 brands · 4 makers in the NepalDoc catalog — see the full Testosterone Enanthate guide →
Storage at low temperatures.
Storage information from the U.S. FDA-approved label for Testosterone Enanthate.
What is Sustanon?
Sustanon 100mg Injection is a Testosterone Enanthate medicine made by Zydus Pharmaceuticals. It comes as 100mg Injection.
What is Sustanon used for?
Testosterone Enanthate is used for Inoperable metastatic breast cancer, Delayed puberty, Male hypogonadism.
What is the generic name of Sustanon?
The generic name of Sustanon is Testosterone Enanthate.
Which brands of Testosterone Enanthate are available in Nepal?
6 brands of Testosterone Enanthate are listed in the NepalDoc catalog, from 4 makers — including Cernos Depot 100mg Injection, Sustanon 250mg Injection, Sustanon 100mg Solution, Sustanon 250mg Solution, Testovirondepot 250mg Solution.
What are the side effects of Testosterone Enanthate?
Endocrine and Urogenital, Female – The most common side effects of androgen therapy are amenorrhea and other menstrual irregularities, inhibition of gonadotropin secretion, and virilization, including deepening of the voice and clitoral enlargement.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
